Avastin (bevacizumab)
Avastin is a monoclonal antibody that targets vascular endothelial growth factor A (VEGF-A).
Avastin became the first anti-angiogenic therapy made widely available for the treatment of patients with an advanced cancer.
M-PK-00001196
This information is intended for HCP only. This is a prescription based drug. Please consult your doctor if you need more information.